clinical trial · NCT04150289
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat
Multiple MyelomaFarydak
brief summary
This study aims to describe current treatment patterns in the real-world setting among patients with multiple myeloma who are initiating treatment with (or changing treatment to) panobinostat and explore the associations with baseline patient characteristics, healthcare resource utilization, and clinical outcomes.
started
Nov 4, 2019
primary completion
Mar 30, 2022
completion
Mar 30, 2022
last updated
Jun 15, 2023
official title
A Disease Registry Encompassing the Care of Patients With Multiple Myeloma on Panobinostat (RECOMM)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol